Table 1.
Patient characteristics
| n (%) | |
|---|---|
| Median age (IQR) | 73 (69-79) |
| Median PSA (IQR) | 8 (5.0-19.9 ng/ml) |
| Median SUVmax (IQR) | 18.35 (5.36-27.41) |
| PI-RADS MRI | |
| PI-RADS 1 | 5 (16.7) |
| PI-RADS 2 | 6 (20.0) |
| PI-RADS 3 | 11 (36.7) |
| PI-RADS 4 | 4 (13.3) |
| PI-RADS 5 | 4 (13.3) |
| Biopsy | |
| Negative | 12 (40.0) |
| Positive | 18 (60.0) |
| Gleason score | |
| ≤7 | 11 (61.1) |
| >7 | 7 (38.9) |
IQR: Interquartile range, PSA: Prostate-specific antigen, SUVmax: Maximum standardized uptake value, PI-RADS: Prostate Imaging Reporting and Data System, MRI: Magnetic resonance imaging